Skip to main content
DVA
NYSE Industrial Applications And Services

DaVita Reports Strong Q4 & Full-Year 2025 Results, Exceeding Prior Year Performance and Initiates Positive 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$115.9
Mkt Cap
$7.85B
52W Low
$101
52W High
$179.6
52W Position info
15% above low
Off High info
35% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

DVA is trading near its 52-week low of $101 (15% above the low) on elevated volume (2.4× avg).

Summary

DaVita Inc. announced strong Q4 and full-year 2025 financial results, provided positive 2026 guidance, and highlighted significant share repurchases, signaling robust performance and a commitment to shareholder returns.


Key Events · Earnings and Guidance · DVA

  • Strong Q4 and Full-Year 2025 Financial Performance

    DaVita reported consolidated revenues of $3.620 billion for Q4 2025 and $13.643 billion for the full year, with adjusted diluted EPS of $3.40 for Q4 and $10.78 for the full year, both exceeding prior periods.

  • Positive 2026 Financial Guidance Issued

    The company provided an optimistic outlook for 2026, projecting adjusted operating income between $2.085 billion and $2.235 billion, and adjusted diluted net income per share from continuing operations between $13.60 and $15.00.

  • Significant Share Repurchase Program

    DaVita repurchased 2.7 million shares for $331 million in Q4 2025, and an additional 1.7 million shares for $200 million subsequent to quarter-end. Total repurchases for 2025 amounted to 12.7 million shares for $1.788 billion, indicating a substantial capital return to shareholders.

  • Debt Refinancing Strengthens Balance Sheet

    The company refinanced its existing Term Loan A-1 and revolving line of credit facilities with a new $2.0 billion Term Loan A-2 and a $1.5 billion revolving line of credit, enhancing financial flexibility.


Analysis · DVA · Industrial Applications And Services

DaVita Inc. delivered robust financial results for both the fourth quarter and full year 2025, surpassing prior year performance across key metrics including revenue, operating income, and adjusted diluted EPS. The company also provided an optimistic outlook for 2026, projecting continued growth in adjusted operating income and adjusted diluted EPS. A significant highlight is the company's substantial capital return to shareholders through share repurchases, with $331 million executed in Q4 2025 and an additional $200 million post-quarter, following a massive $1.788 billion in repurchases for the full year. This demonstrates strong management confidence and commitment to shareholder value. The successful refinancing of existing debt facilities further strengthens the company's financial position, while an impairment related to the Mozarc investment represents a minor offset in an otherwise strong report.

How filings like this one have moved

In the 30 days to Sep 16, 2026, 35.8% of the 1190 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DVA was trading at $115.90 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.9B. The 52-week trading range was $101.00 to $179.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $190.90 info
Change: +$8.20 (+4%) info
Market Cap: $12.179B info
DVA
Aug 25, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $176.50
Real-time Price: $190.90 info
Change: +$14.40 (+8%) info
Market Cap: $12.179B info
DVA
Aug 04, 2026, 4:36 PM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $214.99
Real-time Price: $190.90 info
Change: -$24.09 (-11%) info
Market Cap: $12.179B info
DVA
Aug 04, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $218.00
Real-time Price: $190.90 info
Change: -$27.10 (-12%) info
Market Cap: $12.179B info
DVA
Aug 04, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $211.90
Real-time Price: $190.90 info
Change: -$21.00 (-10%) info
Market Cap: $12.179B info